Clinical study and effect on the uterine receptor of the combination Norgestrel-Ethinyl-Estradiol (FH 122-A) in 500 menstrual cycles
Lévrier, M.
Bordeaux Medical 3(1): 225-226
1970
ISSN/ISBN: 0021-7867 PMID: 4948561 Document Number: 508480
Document emailed within 1 workday
Related Documents
Oride, A.; Kanasaki, H.; Miyazaki, K. 2014: Disappearance of a uterine arteriovenous malformation following long-term administration of oral norgestrel/ethinyl estradiol Journal of Obstetrics and Gynaecology Research 40(6): 1807-1810Murray, E.; Bosch, L.R.; Lema, B.E. 1970: Clinical research on a new progestagen (norgestrel) combined with ethinyl estradiol Prensa Medica Argentina 57(31): 1485-1494
Korba, V.D.; Heil, C.G. 1975: Eight years of fertility control with norgestrel-ethinyl estradiol (Ovral): an updated clinical review Fertility and Sterility 26(10): 973-981
Arjuman, A.; Pandey, H.; Chandra, N.C. 2011: Effect of a combination oral contraceptive (desogestrel+ethinyl estradiol) on the expression of low-density lipoprotein receptor and its transcription factor (SREBP2) in placental trophoblast cells Contraception 84(2): 160-168
Givens, J.R.; Fort, A.T.; Leigh, J.H. 1968: Effect of norgestrel in combination with ethinyl oestradiol on the human pituitary-adrenal axis Journal of Reproduction and Fertility. Suppl 5(Suppl 5): 69-76
Givens, J.R.; Fort, A.T.; Leigh, J.H. 1968: Effect of norgestrel in combination with ethinyl oestradiol on the human pituitary-adrenal axis Journal of Reproduction and Fertility. Suppl 5(Suppl 5): 69-76
Skouby, S.O. 1987: Oral contraception with a triphasic combination of gestodene and ethinyl estradiol: results of a multicenter clinical study International Journal of Fertility 32 Suppl: 45-48
Krishnan, S.; Kiley, J. 2010: The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μg International Journal of Women's Health 2: 235-239
Mehta, S.; Joshi, U.M.; Sankolli, G.M.; Adatia, A.; Donde, U.M.; Saxena, B.N. 1981: Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and D-norgestrel Contraception 23(3): 241-250
Balogh, A.; Irmisch, E.; Wolf, P.; Letrari, S.; Splinter, F.K.; Hempel, E.; Klinger, G.; Hoffmann, A. 1991: Effect of levonorgestrel and ethinyl estradiol and their combination on biotransformation reactions Zentralblatt für Gynakologie 113(24): 1388-1396
Creinin, M.D.; Lippman, J.S.; Eder, S.E.; Godwin, A.J.; Olson, W. 2002: The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol Contraception 66(3): 147-152
De Andrade, R.P. 1989: A multicenter clinical evaluation of a new monophasic combination: Minulet (gestodene and ethinyl estradiol) International Journal of Fertility 34 Suppl: 22-30
Kashanian, M.; Shahpourian, F.; Zare, O. 2010: A comparison between monophasic levonorgestrel-ethinyl estradiol 150/30 and triphasic levonorgestrel-ethinyl estradiol 50-75-125/30-40-30 contraceptive pills for side effects and patient satisfaction: a study in Iran European Journal of Obstetrics Gynecology and Reproductive Biology 150(1): 47-51
DelConte, A.; Loffer, F.; Grubb, G.S. 1999: Cycle control with oral contraceptives containing 20 micrograms of ethinyl estradiol. a multicenter, randomized comparison of levonorgestrel/ethinyl estradiol (100 micrograms/20 micrograms) and norethindrone/ethinyl estradiol (1000 micrograms/20 micrograms) Contraception 59(3): 187-193
Galán, G.; Gayán, P.; Tisné, L. 1985: Laboratory and clinical study with a new progestagen combined with ethinyl estradiol used in contraception Revista Chilena de Obstetricia y Ginecologia 50(4): 317-324
Galán, G.; Gayán, P.; Tisné, L. 1985: Laboratory and clinical study with a new progestagen combined with ethinyl estradiol used in contraception Revista Chilena de Obstetricia y Ginecologia 50(4): 317-324
Davis, A.; Godwin, A.; Lippman, J.; Olson, W.; Kafrissen, M. 2000: Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding Obstetrics and Gynecology 96(6): 913-920
Hanson, F.W.; Niswander, K.R. 1974: A new low dose norethindrone acetate (0.6 mg) ethinyl estradiol (30 mcg) combination oral contraceptive Journal of Reproductive Medicine 12(3): 109-111
Ruíz Moreno, J.A.; Rubio Lotvin, B.; Bolio Arista, R.; de Larios, N.M. 1977: A continuous experience of the use of norethindrone-ethinyl estradiol combination in small doses as a contraceptive Ginecologia y Obstetricia de Mexico 41(244): 179-184
Gaussem, P.; Alhenc-Gelas, M.; Thomas, J.-L.; Bachelot-Loza, C.; Remones, V.; Ali, F.D.; Aiach, M.; Scarabin, P.-Y. 2011: Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. a double-blind, randomised study Thrombosis and Haemostasis 105(3): 560-567